These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 3628863)
1. Immunoscintigraphy of gastric or colon carcinoma with F(ab')2 fragments of anti-CEA monoclonal antibody. Amendolagine F; Allegra V; Tenti M; Lobrano V; Pannozzo G Rays; 1987; 12(1):67-71. PubMed ID: 3628863 [No Abstract] [Full Text] [Related]
2. Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody. Buraggi G; Callegaro L; Turrin A; Gennari L; Bombardieri E; Mariani G; Deleide G; Dovis M; Gasparini M; Doci R Cancer Detect Prev; 1987; 10(5-6):335-45. PubMed ID: 3568032 [TBL] [Abstract][Full Text] [Related]
3. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies. Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753 [TBL] [Abstract][Full Text] [Related]
4. Radiolocalisation of an anti-CEA monoclonal antibody (FO23C5) and its fragments in a colon carcinoma xenograft model. Rowlinson G; Paganelli G; Snook D; Epenetos AA Int J Biol Markers; 1988; 3(4):259-64. PubMed ID: 3235854 [TBL] [Abstract][Full Text] [Related]
5. Immunoscintigraphy of colon carcinoma. Chatal JF; Saccavini JC; Fumoleau P; Douillard JY; Curtet C; Kremer M; Le Mevel B; Koprowski H J Nucl Med; 1984 Mar; 25(3):307-14. PubMed ID: 6366160 [TBL] [Abstract][Full Text] [Related]
6. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids. Sutherland R; Buchegger F; Schreyer M; Vacca A; Mach JP Cancer Res; 1987 Mar; 47(6):1627-33. PubMed ID: 3545451 [TBL] [Abstract][Full Text] [Related]
7. [Immunoscintigraphy of cancer of the ovaries and colon using labeled monoclonal antibodies]. Gabuniia RI; Shiriaev SV; Bogdasarov IuB; Zhordaniia KI; Anan'ev VS Med Radiol (Mosk); 1989 Aug; 34(8):56-61. PubMed ID: 2770446 [TBL] [Abstract][Full Text] [Related]
8. [Immunoscintigraphy, an aid to the oncologist--the Rennes experience in using anti-CEA, anti-CA 19.9 monoclonal antibodies and radiolabelled OC-125]. Herry JY; Bourguet P; Kerbrat P; Le Prise E; Ben Hassel M; Gedouin D; Richier JL Allerg Immunol (Paris); 1987 May; 19(5):180-8. PubMed ID: 3330945 [TBL] [Abstract][Full Text] [Related]
10. Immunoscintigraphy of adenocarcinomas by means of 111In-labelled F(ab')2 fragments of anti-CEA monoclonal antibody F023C5. Riva P; Paganelli G; Callegaro L; Bartoli MG; Turci D; Benini S; Deleide G; Scassellati GA; Viale G; Siccardi AG Nucl Med Commun; 1988 Aug; 9(8):577-89. PubMed ID: 3173916 [TBL] [Abstract][Full Text] [Related]
11. Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments. Buchegger F; Pfister C; Fournier K; Prevel F; Schreyer M; Carrel S; Mach JP J Clin Invest; 1989 May; 83(5):1449-56. PubMed ID: 2708519 [TBL] [Abstract][Full Text] [Related]
12. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody. Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542 [TBL] [Abstract][Full Text] [Related]
13. A comparison of iodine and indium labelled anti CEA intact antibody, F(ab)2 and Fab fragments by imaging tumour xenografts. Andrew SM; Perkins AC; Pimm MV; Baldwin RW Eur J Nucl Med; 1988; 13(11):598-604. PubMed ID: 3350036 [TBL] [Abstract][Full Text] [Related]
14. A rapid method for the determination of human CEA/mouse anti-CEA immune complexes in patients undergoing immunoscintigraphy. Baum RP; Driever PH; Drahovsky D; Hör G Eur J Nucl Med; 1989; 15(6):321-5. PubMed ID: 2767081 [TBL] [Abstract][Full Text] [Related]
16. Cancer detection by immunoscintigraphy, selection, and clinical application of monoclonal anti-CEA antibodies and their F(ab')2 or Fab fragments. Grob JP; Mach JP; Buchegger F; Schreyer M; Mosimann F; Besson A; Pettavel J; von Fliedner V; Bischof-Delaloye A; Delaloye B Recent Results Cancer Res; 1986; 100():73-9. PubMed ID: 3488573 [No Abstract] [Full Text] [Related]
17. Tumor scintigraphy with 131I anti CEA monoclonal antibodies and F(ab')2 in colorectal cancer. Henze E; Kübel R; Waitzinger J; Büchler M; Adam WE; Beger HG Eur J Nucl Med; 1987; 13(3):125-9. PubMed ID: 3622555 [TBL] [Abstract][Full Text] [Related]
18. Immunoscintigraphy in medullary thyroid cancer using an 123I- or 111In-labelled monoclonal anti-CEA antibody fragment. Reiners C; Eilles C; Spiegel W; Becker W; Börner W Nuklearmedizin; 1986 Dec; 25(6):227-31. PubMed ID: 3808964 [TBL] [Abstract][Full Text] [Related]
19. Efficient targeting of gastric cancer cells using radiolabeled anti-carcinoembryonic antigen-specific T84.66 fragments in experimental radioimmunoguided surgery. Kim JC; Hong HK; Roh SA; Koo KH; Ka IH; Namgung H; Lee KH; Ryu JH; Yu CS; Oh SJ; Ryu JS; Kim JS; Kim HC Anticancer Res; 2004; 24(2B):663-70. PubMed ID: 15161009 [TBL] [Abstract][Full Text] [Related]
20. Iodine-131-labeled MAb F(ab')2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice. Buchegger F; Pèlegrin A; Delaloye B; Bischof-Delaloye A; Mach JP J Nucl Med; 1990 Jun; 31(6):1035-44. PubMed ID: 2348233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]